PA
ADAM

PharVision Advisers’s Adamas Trust ADAM Stock Holding History

PharVision Advisers’s Portfolio ADAM Stock Details ADAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,328
Closed -$109K – 751
2025
Q2 		$109K Buy
+16,328
New +$104K 0.16% 249

Other funds holding ADAM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

PharVision Advisers's ADAM Position: Q3 2025 in Review

PharVision Advisers sold out of Adamas Trust (ADAM) in Q3 2025, closing a stake of 16,328 shares — an estimated $109K sold.

PharVision Advisers first reported a position in ADAM in Q2 2025 and held it in 1 quarter. The position peaked at $109K in Q2 2025. 170 funds tracked by Wall St. Rank hold ADAM as of Q3 2025.

  • PharVision Advisers reported no remaining Adamas Trust position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 16,328 Adamas Trust shares in Q3 2025, an estimated $109K.
  • PharVision Advisers first reported a position in Adamas Trust in Q2 2025 and held it in 1 quarter.
  • PharVision Advisers's Adamas Trust position peaked at $109K in Q2 2025.
  • 170 funds tracked by Wall St. Rank held Adamas Trust as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.